HM Payson & Co’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$320K Buy
7,495
+225
+3% +$12.2K ﹤0.01% 371
2026
Q1
$456K Buy
7,270
+378
+5% +$30.2K 0.01% 310
2025
Q4
$657K Buy
6,892
+198
+3% +$19.4K 0.01% 267
2025
Q3
$654K Sell
6,694
-181
-3% -$18.7K 0.01% 258
2025
Q2
$738K Hold
6,875
0.01% 240
2025
Q1
$694K Buy
6,875
+98
+1% +$9.87K 0.01% 248
2024
Q4
$605K Sell
6,777
-6
-0.1% -$528 0.01% 263
2024
Q3
$568K Buy
6,783
+30
+0.4% +$2.37K 0.01% 273
2024
Q2
$520K Hold
6,753
0.01% 268
2024
Q1
$463K Buy
6,753
+83
+1% +$5.34K 0.01% 291
2023
Q4
$386K Sell
6,670
-936
-12% -$50K 0.01% 304
2023
Q3
$402K Buy
7,606
+2,236
+42% +$117K 0.01% 289
2023
Q2
$290K Sell
5,370
-150
-3% -$7.83K 0.01% 320
2023
Q1
$276K Buy
5,520
+4,286
+347% +$202K 0.01% 320
2022
Q4
$57.1K Sell
1,234
-55
-4% -$2.38K ﹤0.01% 539
2022
Q3
$50K Buy
1,289
+88
+7% +$3.53K ﹤0.01% 572
2022
Q2
$45K Sell
1,201
-32
-3% -$1.3K ﹤0.01% 593
2022
Q1
$55K Buy
1,233
+33
+3% +$1.43K ﹤0.01% 579
2021
Q4
$51K Hold
1,200
﹤0.01% 600
2021
Q3
$52K Hold
1,200
﹤0.01% 584
2021
Q2
$51K Hold
1,200
﹤0.01% 579
2021
Q1
$46K Hold
1,200
﹤0.01% 617
2020
Q4
$43K Buy
1,200
+150
+14% +$5.41K ﹤0.01% 624
2020
Q3
$40K Hold
1,050
﹤0.01% 599
2020
Q2
$37K Buy
1,050
+250
+31% +$9K ﹤0.01% 559
2020
Q1
$26K Sell
800
-274
-26% -$10.7K ﹤0.01% 593
2019
Q4
$49K Sell
1,074
-225
-17% -$9.41K ﹤0.01% 596
2019
Q3
$53K Hold
1,299
﹤0.01% 586
2019
Q2
$56K Buy
+1,299
New +$50K ﹤0.01% 581

Other funds holding BSX

HM Payson & Co's BSX Position: Q2 2026 in Review

HM Payson & Co increased its Boston Scientific (BSX) stake by 3.1% in Q2 2026, buying an estimated $12.2K and bringing the position to 7,495 shares worth $320K. The position accounts for ﹤0.01% of the portfolio, ranked #371.

HM Payson & Co first reported a position in BSX in Q2 2019 and has held it in 29 quarters since. The position peaked at $738K in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • HM Payson & Co held 7,495 shares of Boston Scientific worth $320K as of Q2 2026.
  • HM Payson & Co bought 225 Boston Scientific shares in Q2 2026, an estimated $12.2K.
  • Boston Scientific made up ﹤0.01% of HM Payson & Co's portfolio in Q2 2026, its #371 holding.
  • HM Payson & Co first reported a position in Boston Scientific in Q2 2019 and has held it in 29 quarters since.
  • HM Payson & Co's Boston Scientific position peaked at $738K in Q2 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on HM Payson & Co's 13F filing for Q2 2026, filed 17 Jul 2026.